norUrsodeoxycholic acid

DRUG2 trials

Sponsors

Dr. Falk Pharma GmbH

Conditions

Nonalcoholic SteatohepatitisPrimary Sclerosing Cholangitis

Phase 2

Norursodeoxycholic Acid vs. Placebo in NASH

RecruitingNCT05083390

Dr. Falk Pharma GmbHNonalcoholic Steatohepatitis

Start: 2019-07-08End: 2025-04-30Target: 363Updated: 2024-02-20

Phase 3

norUrsodeoxycholic Acid vs Placebo in PSC

Active, not recruitingNCT03872921

Dr. Falk Pharma GmbHPrimary Sclerosing Cholangitis

Start: 2018-02-08End: 2026-06-30Updated: 2024-08-06